Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

11 November 2015

RiverVest closes $40.5m Series C round in US Amplyx Pharmaceuticals

laboratory-829371_1920 Life sciences-focused RiverVest Venture Partners has led a $40.5m Series C round in Amplyx Pharmaceuticals, a San-Diego based developer of treatments of life-threatening fungal infections.

2 November 2015

Warburg Pincus backs Polish pharmacy chain Gemini

pharmacy-218692_1920 Global private equity major Warburg Pincus is the new partner of Apteki Gemini, the Gdansk-based pharmacy operator has announced.

8 October 2015

Genstar backs drug industry solutions provider PSKW

pills-943764_1280 Genstar Capital has made “a substantial investment” in New Jersey-based PSKW, tapping its recently closed seventh fund for the first time.

6 May 2015

RiverVest to target pharma, medical devices with new $80.2m fund

pharmaceutical-12_sq Life sciences-focused RiverVest Venture Partners plans to target the pharmaceutical and therapeutic medical device sectors after closing its third fund on just over $80m.

6 February 2015

Hercules, Capital Ten, lift heart disease researcher to $23.3m Series B

untitled-1238683-m Hercules Bioventure Partners and Capital Ten have led a $23.3m Series B round for cardiovascular drugs company Armetheon.

27 January 2015

Chinese venture firm Legend Capital leads $100m round for Innovent Biologics

china-flag-1421043-m Beijing-headquartered Legend Capital has led a $100 m Series C financing round for Chinese pharmaceuticals group Innovent Biologics. Singapore-based investment company Temasek, with S$223bn ($178 bn) in AUM also took part in the round said Innovent. PE firms already invested in Innovent include Fidelity Biosciences, Fidelity Growth Partners Asia, Lilly Asia Ventures, and Frontline Bioventures.[...]

13 January 2015

Qualcomm Ventures forms $100m investment partnership with Novartis

syringe-974378-m Qualcomm Ventures, the venture capital arm of Qualcomm Incorporated, has partnered with Novartis Pharmaceuticals to target early stage companies in the healthcare tech sector.

30 October 2014

Warburg Pincus buys stake in India pharmaceutical Laurus Labs for $90m

download (1) Global private equity firm Warburg Pincus has invested INR5.5bn (around $90m) for a stake in Laurus Labs Private Limited, an Indian developer and manufacturer of Active Pharmaceutical Ingredients.

2 October 2014

Venture capital-backed Alios BioPharma sold to Johnson & Johnson for $1.75bn

sale-1306463-m Clinical stage biopharmaceutical company Alios BioPharma has been bought by multinational healthcare business Johnson & Johnson for around $1.75bn in cash.

15 September 2014

EIF investment helps NeoMed close Fund V on €92.1m

medical-care-962546-m Medical-focused venture capital firm NeoMed Management has held the final close of its Innovation V fund on €92.1m ($122m).

Page 1 of 712345...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015